menu
    • menu
    [{"orgOrder":0,"company":"Avidicure","sponsor":"EQT Life Sciences","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"NETHERLANDS","productType":"Antibody, Unconjugated","year":"2025","type":"Financing","leadProduct":"AVC-S-101","moa":"Trop2","graph1":"Oncology","graph2":"IND Enabling","graph3":"Avidicure","amount2":0.050000000000000003,"highestDevelopmentShortName":"IND","therapeuticAreaShortName":"Oncology","amount2New":0.050000000000000003,"dosageForm":"Undisclosed","sponsorNew":"Avidicure \/ EQT Life Sciences","highestDevelopmentStatusID":"5","companyTruncated":"Avidicure \/ EQT Life Sciences"}]

    Find Clinical Drug Pipeline Developments & Deals by Avidicure

    Menu

    Avidicure

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Avidicure

                            Netherlands arrow
                            Global ChemShow
                            Not Confirmed

                            Avidicure

                            Netherlands arrow
                            Global ChemShow
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : AVC-S-101

                            Therapeutic Area : Oncology

                            Study Phase : IND Enabling

                            Sponsor : EQT Life Sciences

                            Deal Size : $50.0 million

                            Deal Type : Financing

                            DEALS_DEV arrow-down

                            Avidicure Launches with $50M Seed Round to Develop Cancer Antibody Therapy

                            Details : The financing aims to advance the clinical development of lead product AVC-S-101, a TROP2-targeting booster being developed for non-small cell lung cancer and multiple other cancer indications.

                            Product Name : Undisclosed

                            Product Type : Antibody, Unconjugated

                            Upfront Cash : Undisclosed

                            April 24, 2025

                            Lead Product(s) : AVC-S-101

                            Therapeutic Area : Oncology

                            Highest Development Status : IND Enabling

                            Sponsor : EQT Life Sciences

                            Deal Size : $50.0 million

                            Deal Type : Financing

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth